James Gordon Analyst PerformanceExecutive Director, European Pharma and Biotech Equity Research at JPMorgan Chase & Co.James Gordon is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 5 publicly traded companies. Over the past year, James Gordon has issued 5 stock ratings, including buy, hold, and sell recommendations. While full access to James Gordon's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights James Gordon's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings11 Last 11 YearsBuy Recommendations45.45% 5 Buy RatingsCompanies Covered5 Unique Companies Ratings Distribution11RatingsDistribution of strong buy, buy, hold, and sell ratings by James Gordon.RatingPercentageCount Strong Buy0.0%0 ratings Buy45.5%5 ratings Hold36.4%4 ratings Sell18.2%2 ratingsOut of 11 total stock ratings issued by James Gordon at JPMorgan Chase & Co., the majority (45.5%) have been Buy recommendations, followed by 36.4% Hold and 18.2% Sell.Best & Worst CallsBest Call000.0%ARGXAug 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%ARGXNov 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ60.0% of companies on NASDAQ3 companiesNYSE40.0% of companies on NYSE2 companiesJames Gordon, an analyst at JPMorgan Chase & Co., currently covers 5 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare5 companies100.0%James Gordon of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY3 companies60.0%PHARMACEUTICALS2 companies40.0% James Gordon's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGMABGenmab A/S10/26/2026Upgrade$43.79Overweight$0.0000.00% ROIGSKGSK2/20/2026Reiterated Rating$59.56Underweight$0.0000.00% ROIGSKGSK1/6/2026Downgrade$50.45Underweight$0.0000.00% ROIARGXargenex12/8/2025Boost Price Target$910.87$1,100.00Overweight$0.0000.00% ROIGRFSGrifols12/8/2025Lower Price Target$8.96$10.00Neutral$0.0000.00% ROIARGXargenex11/7/2025Boost Price Target$850.26$925.00Overweight$000.0000.00% ROIARGXargenex8/4/2025Boost Price Target$679.46$830.00Overweight$000.0000.00% ROIGRFSGrifols6/17/2025Boost Price Target$9.09$10.30Neutral$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
